The evolution of open radio access network infrastructure through AI integration and a discrete focus on underlying ...

NewcelX Ltd., a clinical-stage company, has entered a strategic collaboration with Eledon Pharmaceuticals Inc., a ...

Semtech acquires HieFo Corporation for $34M, adding InP technology to its AI data center portfolio. Read about this major ...

NewcelX Ltd. ("NewcelX") (Nasdaq: NCEL), a clinical-stage company advancing stem-cell-derived therapies for Type 1 Diabetes, today announced a collaborative research agreement with Eledon ...

Hormonal dysregulation and gut microbiota alterations as potential contributors to cognitive dysfunction CHINA, March ...

Collaboration Integrates Stem-Cell-Derived Islets with Targeted Immune Modulation ZURICH, Switzerland, March 9, 2026 /PRNewswire/ -- NewcelX Ltd. ("NewcelX") (Nasdaq: ...

SemiTech’s blended analyst fair value estimate has moved from US$83.43 to US$90.38 per share, giving you an updated reference point for what the Street thinks the stock is worth. Analysts linking this ...

Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the ...

Scientists in China have developed a metasurface platform that realizes true three-dimensional (3D) vectorial holography by ...

Quectel Wireless Solutions, a global end-to-end IoT solutions provider, today announces the FCE870Q Wi-Fi7 and Bluetooth 6.0 ...

Kyowa Kirin has decided to discontinue all clinical development of its OX40 drug after two new cancer cases emerged. | Kyowa Kirin has decided to discontinue all clinical development of its OX40 drug ...

Real-world PRECISION data in 500 taxane-naïve, PSMA-positive mCRPC patients showed median PFS 13.5 months (95% CI, 11.7–14.7), aligning with PSMAfore efficacy expectations. Earlier sequencing mattered ...